Cardiovascular Disease Development Expertise

Veristat is passionate about advancing breakthrough therapies that treat and manage cardiovascular disease. Our end-to-end clinical trial consultation, operations, and regulatory solutions span trial design and execution through to regulatory submission.

Our Cardiovascular Disease Experience by the Numbers

  • >200 Cardiovascular Trials for drugs, biologics, devices, and diagnostics
  • 5 Approved Marketing Applications to date
  • 42% of the Cardiovascular Trials for rare diseases

Explore Our Recent Cardiology Experience


Learn More with These Resources

Case Study
Writing Multiple Marketing Applications At The Same Time

A mid-size pharmaceutical company and its development partner, a small biotechnology company engaged Veristat to complete the medical writing for their product’s ...

Fact Sheet
Cardiovascular Experience Fact Sheet

With Cardiovascular Diseases being the leading cause of death worldwide, Veristat is committed to supporting cardiovascular clinical trials to make a difference in ...

Case Study
Exceeding Expectations For Patient Enrollment Case Study

When Veristat partnered with a US based biotechnology company on a Phase II study for a topical spray to treat hypertension, our emphasis on effective planning and ...

Request A Proposal